Please Subscribe to get a daily link to Pat's blog via email

Subscribe!

Your privacy is important to us. We will never spam you and keep your personal data secure.

Erythropoietin Suppresses Multiple Myeloma, Prolonging & Improving the Patients’ Lives

Home/Erythropoietin Suppresses Multiple Myeloma, Prolonging & Improving the Patients’ Lives

Erythropoietin Suppresses Multiple Myeloma, Prolonging & Improving the Patients’ Lives

Here is a link and a few excerpts from a PRNewswire article yesterday:  XTL Completes Acquisition of Bio-Gal:

XTL is engaged in the development of therapeutics to treat diseases for which no medical cure has yet been discovered. The Company is focused on developing a drug for the treatment of multiple myeloma and Hepatitis C.

– Research and Clinical Observations of MM Terminal Patients by Bio-Gal Suggests That Treatment with Erythropoietin Suppresses the Disease, Prolonging and Improving the Patients’ Lives.

– XTL is Commencing Preparations to Begin a Phase 2 Clinical Trial in Multiple Myeloma Patients.

I am not familiar with erythropoietin.  Research is currently being conducted in Isreal.  Prof. Moshe Mittelman, a hematologist of international repute and director of the Division of Internal Medicine at Ichilov Hospital in Tel Aviv, reports ” Erythropeietin is helpful in suppressing the disease by “strengthening” the immune-system function, prolonging survival and inducing improvement in the quality of life.”

Keep these new anti-myeloma therapies coming!  The more the better. 
Feel good and keep smiling!  Pat